Trial
NCT01729338
Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Duke University
Collaborators
Millennium Pharmaceuticals, Inc.; Duke Cancer Institute
Condition
Multiple Myeloma
Intervention
Velcade
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-31